Publications, Pharmaceutical

Why it is time to think differently about Nasal delivery of Biologics

COVID-19 has reinvigorated interest in the advantages of nasal delivery for a pharmaceutical industry already embracing a shift towards biologics.

This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.

Download Publication
Author(s): Gemma Budd Irene Rossi
4 Apr 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

17 Jul 2019

New Tools to Advance CNS Drug Delivery

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Market Insights, Product Solutions

Read More
1 Jul 2019

Aptar Pharma discusses challenges and benefits of drug repurposing

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
3 Jun 2019

Microbial integrity testing for preservative-free drug formulations

Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations

Read More
1 Apr 2019

Interview with Guillaume Brouet on Aptar Pharma Services

Publications, Pharmaceutical, Innovation & Insights

Read More
1 … 23 24 25 26 27

How Can We Help?

Back To Top